You searched for Parkinson's - Page 16 of 20

Best in Biotech 28 Dec 2020

A Year to Remember: The Biggest European Biotech News in 2020

…AI chips that rewire us to treat conditions like Parkinson’s disease. The German firm CureVac started the development of a vaccine for the emerging viral disease Covid-19. CureVac’s candidate is…

December 28, 2020 - 12 minutesmins - By Jonathan Smith

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

…pipeline was built around four small-molecule-based drug candidates that aim to treat Parkinson’s disease and rare diseases, which are all presently in preclinical stages. Kite and Arcellx continue oncology partnership…

November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

News and Trends 6 Jun 2022

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

…is working in the field of mitochondrial biology to treat Parkinson’s, motor neuron disease and other neurodegenerative disorders, received a $5.8M Biomedical Catalyst (BMC) award to fund preclinical development of…

June 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Research identifies new treatment target for CNS injury and neurological disease

…Optic nerve damage was of interest to the researchers because it occurs in patients with glaucoma, multiple sclerosis, Alzheimer’s and Parkinson’s disease. Here the animal models showed that administration of…

September 22, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 18 Apr 2024

5 RNA editing companies you should know about

…innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more. In August 2021, Shape…

April 18, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 11 Apr 2023

PsychoGenics launches eCube AI platform for drug discovery

…research in areas such as Huntington’s disease, autism spectrum disorders, psychosis/schizophrenia, depression, PTSD, Alzheimer’s disease, Parkinson’s disease, muscular dystrophy, ALS and seizure disorders. PsychoGenics featured recently in Labiotech’s feature on…

April 11, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 14 May 2024

Six biotechs in Belgium making leaps in the clinic

…safety endpoint. The biopharma is also engaged in the discovery of drugs for Parkinson’s disease, type 1 diabetes, and an autoimmune disease called spondyloarthritis that affects the spine and the…

May 14, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 17 Sep 2021

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

…and at a better quality than current cell therapy manufacturing techniques. TreeFrog is also developing its own cell therapy candidates, starting with a Parkinson’s disease therapy due to enter phase…

September 17, 2021 - 8 minutesmins - By Helen Albert

In Depth 12 Jul 2023

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

…to lowering the risk of Parkinson’s and other neurodegenerative diseases. The organization’s Microbiome Network enables members to collaborate on drug discovery, nutrition and probiotic development. A prominent player in the…

July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 25 Jan 2024

The trends that will shape the biotech industry in 2024

…and extend research and development timelines. Furthermore, the use of stem cell technologies for purposes like drug testing, disease simulation, and the treatment of neurodegenerative diseases, such as Parkinson’s and…

January 25, 2024 - 13 minutesmins - By Jules Adam

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

…a T-regulatory (Treg) candidate focused on lung cancer targeting the FOXP3 gene. AUM LifeTech also develops a project targeting Parkinson’s disease. BlueWhale Bio BlueWhale Bio, a biotech company founded in…

May 21, 2024 - 10 minutesmins - By Jules Adam

News and Trends 7 Jun 2022

Yumanity selling neurology assets and merging with Kineta

…placed a partial clinical hold on multidose clinical trials of YTX-7739, currently being developed for the treatment of Parkinson’s disease. The FDA did not stop all clinical programming and allowed…

June 7, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

A Year to Remember: The Biggest European Biotech News in 2020

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

Research identifies new treatment target for CNS injury and neurological disease

5 RNA editing companies you should know about

PsychoGenics launches eCube AI platform for drug discovery

Six biotechs in Belgium making leaps in the clinic

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

The trends that will shape the biotech industry in 2024

Eight companies spearheading Philadelphia’s biotech industry

Yumanity selling neurology assets and merging with Kineta

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!